| Primary information |
|---|
| OV_ID | OV_1409 |
| Virus Name | Parovirus |
| Strain | H-1PV |
| Virus type | DNA |
| Virus family | Paroviridae |
| Modification in virus genome | None |
| Virus alone | No |
| Virus in combination iwth drug/radiation | Virus strain in combination with norfloxacin (25 microgram/ml) |
| Immune gene induction in virus genome | No |
| Source of cell line | ATCC |
| Origin of cell line | Human pancreatic adenocarcinoma cell line |
| Cell line | BxPC-3 |
| Concentration of cell line | 0 |
| In-vitro toxicity | NA |
| Assay | MTT assay |
| In-vitro virus concentration | 1 MOI |
| In-vitro result | 30% cell survival |
| Model organism | No |
| In-vivo virus concentration | No |
| In-vivo toxicity | NA |
| In-vivo result | No response |
| Mode of delivery | NA |
| Pathway induction | Induction of apoptosis, activation of caspase 3 |
| Immunogenic effect | NA |
| Clinical trial | NA |
| PMID | 19301953 |